Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) showed up in the 13F filings of 241 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 3,790,557 | 10,936 | 0.29% | $310,370,807.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 3,335,320 | 157,884 | 4.97% | $273,096,002.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 3,004,034 | 4,034 | 0.13% | $245,970,304.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 2,562,154 | -103,544 | -3.88% | $209,789,170.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,399,560 | 127,470 | 5.61% | $196,475,972.00 |
| JENNISON ASSOCIATES LLC | 31 Dec, 2025 | 2,230,069 | -374,511 | -14.38% | $182,598,052.00 |
| Morgan Stanley | 31 Dec, 2025 | 2,040,742 | 128,340 | 6.71% | $167,095,971.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 1,930,325 | 491,326 | 34.14% | $158,062,427.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,188,624 | -1,266,173 | -51.58% | $97,324,533.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,172,427 | 141,386 | 13.71% | $95,998,323.00 |
| Assenagon Asset Management S.A. | 31 Dec, 2025 | 1,127,730 | -120,224 | -9.63% | $92,338,532.00 |
| Invesco Ltd. | 31 Dec, 2025 | 1,012,357 | 75,351 | 8.04% | $82,891,790.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 947,763 | 3,267 | 0.35% | $77,616,160.00 |
| State Street Corp | 31 Dec, 2025 | 929,059 | -7,103 | -0.76% | $76,071,351.00 |
| LORD, ABBETT & CO. LLC | 31 Dec, 2025 | 855,645 | -129,984 | -13.19% | $70,060.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 758,106 | -313,940 | -29.28% | $62,073,719.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 757,408 | 416,396 | 122.11% | $62,016,566.00 |
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 728,644 | -438,883 | -37.59% | $59,661,371.00 |
| FMR LLC | 31 Dec, 2025 | 647,114 | 625,253 | 2,860.13% | $52,985,671.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 615,156 | 16,849 | 2.82% | $50,368,973.00 |